New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cresco Labs Inc.
CL.CN
Shape
US Flag

CNQ

Unprofitable

Unprofitable

992M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

992M

Drug Manufacturers - Specialty & Generic

Next Earning date - 07 Nov 2024

2.18CAD
Shape-0.02 ( -0.91%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-49%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

39%

Quote Panel

Shape
Updated October 29, 2024
1W -7.23 % 1M -3.11 % 3M -0.46 % 1Y 44.37 %

Key Metrics

Shape
  • Market Cap

    992.34M


  • Shares Outstanding

    455.20M


  • Share in Float

    449.98M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    2.18


  • Average Volume

    156818


  • Beta

    1.974


  • Range

    1.52-3.58


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.crescolabs.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.95x

P/S Ratio

1.16x

P/B Ratio

1.5

Debt/Equity

-22.8%

Net Margin

$-0.7

EPS

How CL.CN compares to sector?

P/E Ratio

Relative Strength

Shape

CL.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape501%

2025-Revenue

$0.04

Shape122%

2025-EPS

$122M

Shape1332%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-86%

0.01
vs 0.07

Q4.22

arrow
arrow

N/A

-0.81
vs 0.01

Q1.23

arrow
arrow

N/A

-0.09
vs -0.03

Q2.23

arrow
arrow

N/A

-0.16
vs 0.07

Q3.23

arrow
arrow

N/A

-0.45
vs 0.01

Q4.23

arrow
arrow

+101%

0.01
vs -0.81

Q1.24

arrow
arrow

N/A

-0.02
vs -0.09

Q2.24

arrow
arrow

N/A

-0.22
vs -0.16

Q3.24

arrow
arrow

+102%

0.01
vs -0.45

Q4.24

arrow
arrow

+47%

0.02
vs 0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-2%

210.5M  vs 215.5M

Q4.22

arrow
arrow

-8%

199.6M  vs 217.8M

Q1.23

arrow
arrow

-9%

194.2M  vs 214.4M

Q2.23

arrow
arrow

-9%

197.9M  vs 218.2M

Q3.23

arrow
arrow

-9%

190.6M  vs 210.5M

Q4.23

arrow
arrow

-6%

188.2M  vs 199.6M

Q1.24

arrow
arrow

-5%

184.3M  vs 194.2M

Q2.24

arrow
arrow

-7%

184.4M  vs 197.9M

Q3.24

arrow
arrow

+32%

251.7M  vs 190.6M

Q4.24

arrow
arrow

+41%

265.5M  vs 188.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

0%

-0.00
vs -0.01

Q4.22

arrow
arrow

-29%

-0.29
vs -0.00

Q1.23

arrow
arrow

-5%

-0.05
vs -0.29

Q2.23

arrow
arrow

-6%

-0.06
vs -0.05

Q3.23

arrow
arrow

-27%

-0.27
vs -0.06

Q4.23

arrow
arrow

+1%

0.01
vs -0.27

Q1.24

arrow
arrow

-1%

-0.01
vs 0.01

Q2.24

arrow
arrow

-12%

-0.12
vs -0.01

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News